Found vs Trimi Cost 2026: Which GLP-1 Program Costs Less?
Compare Found and Trimi pricing for compounded semaglutide and tirzepatide in 2026: what each charges per month or per 28-day cycle, what the price includes, the costs outside it, and which option offers better value over time.
More on GLP-1 Provider Comparisons
Quick Answer: Trimi Usually Wins on Total Cost
If you are comparing Found and Trimi strictly on cost, Trimi usually comes out ahead for patients who want straightforward access to compounded semaglutide or tirzepatide. The reason is not just the starting monthly number. It is the full cost structure: what the plan price pays for, how often you are billed, and whether you are paying for program features you may not actually use.
Found's model is built around a broader program that combines medication with behavior-change tools, app features, and coaching-style support. For some patients, that extra structure is a real benefit. For others, it simply makes the bill higher. Trimi is positioned more narrowly around affordable GLP-1 access and ongoing clinical support, which generally leads to a lower and more predictable yearly cost.
How to Compare Fairly
Do not compare only the advertised starting price. Ask what you will pay at maintenance dose, what is included each month, whether shipping is extra, and whether you are locked into a broader membership model.
Feature-by-Feature Cost Comparison
The most useful cost comparison is not "Which one sounds cheaper?" but "Which one costs less over a full treatment year for the type of care I actually want?" Here is the practical side-by-side view.
| Cost Factor | Found | Trimi |
|---|---|---|
| Price structure (compounded semaglutide) | One price per 28-day cycle by plan length: $169 (12 months) to $289 (month to month) on cash pay, medication included | One monthly price: $99 on the annual plan (12-month commitment) or $175 month to month, medication included |
| Behavioral/app layer | Core part of the value proposition | More streamlined support model |
| Price at higher doses | Same at every dose | Same at every dose |
| Best fit | Patients who want coaching and app tools | Patients who want lower-cost medication access |
| Billing cadence | Every 28 days (13 cycles a year on month to month) | Monthly, or billed upfront for the annual plan |
| 12-month cost (semaglutide) | From $2,028 on a 12-month cash-pay plan | $1,188 on the annual plan |
Why Found Can Cost More Than Expected
Patients often start with Found because the platform looks comprehensive and modern. The app feels more like a full weight-loss ecosystem than a simple prescription service. That positioning makes sense from a branding standpoint, but it can blur the line between what you are paying for clinically and what you are paying for as part of a broader wellness product.
The biggest issue is not necessarily that Found is overpriced. It is that the value equation changes depending on the patient. If you actively use the behavioral tools, stay engaged with coaching-style support, and want a more programmatic experience, then the premium may feel justified. But if your real goal is competent provider oversight and reliable access to medication at the lowest practical cost, then those bundled features can function like a markup.
This matters most on month-to-month plans. Found discounts the first cycle and then charges its full rate: $179, then $289 per cycle for compounded semaglutide on cash pay. Patients comparing cash-pay providers should focus on the months they will actually spend at the ongoing rate, not just the lower-cost onboarding month. For more context, see our Found semaglutide cost breakdown and Found tirzepatide cost guide.
The month-to-month plan's first-cycle discount ends after one cycle
28-day billing cycles and separate cash and insurance tracks make apples-to-apples comparisons harder
You may be paying for app features you rarely use after the first month
Yearly cost can look much different from the advertised entry price
Where Trimi Creates Savings
Trimi's pricing advantage comes from focus. The company is not trying to be a lifestyle app, a habit-building platform, and a general telehealth brand at the same time. It is built around helping patients access GLP-1 treatment with fewer pricing variables and a simpler care model. That narrower operating model usually translates into lower overhead and cleaner pricing for the patient.
The practical result is better budgeting. Patients who stay on GLP-1 therapy for a year or longer often care more about predictability than a temporary promo. They want to know what the real cost of treatment will be if they stay on course. That is where Trimi tends to outperform Found. The savings may look small month to month, but over twelve or eighteen months they become substantial.
Lower cost also changes the psychology of staying on treatment. When the program feels financially sustainable, patients are less likely to stop because of billing stress, less likely to stretch doses inappropriately, and less likely to abandon an effective therapy too early. If you are comparing providers mainly on value, our guides to the cheapest GLP-1 injections in 2026 and how to get GLP-1 online help place both options in the broader market.
Simpler pricing usually makes annual budgeting easier
A narrower model reduces the chance you are paying for extras you do not need
Predictable cost supports long-term adherence for cash-pay patients
The savings become more meaningful over a full year than they look in a single month
Who Should Pay More for Found Anyway?
Cost leadership is not the only reason patients choose a provider. Some people are more successful when they have a digital ecosystem around them: a structured app, behavior prompts, accountability touchpoints, and a stronger sense of being enrolled in a program rather than simply receiving treatment. Found is trying to serve that patient.
If that is you, Found's higher total cost may still be rational. Paying more can be worthwhile when the extra features improve adherence, motivation, or consistency enough to keep you engaged in treatment. But the key is honesty. If you know from experience that you stop opening apps after two weeks, then the premium is probably not buying you much. In that case, an option like Trimi will likely provide better value.
A good rule is to ask a simple question: "Am I paying extra for actual clinical support, or am I mostly paying for product packaging around the medication?" The answer usually makes the better choice obvious.
Bottom Line on Found vs Trimi Cost
For patients who want the lowest realistic cost for high-quality cash-pay GLP-1 care, Trimi is usually the better value. It costs less than Found's cash-pay plans on both the annual and month-to-month terms, and it is simpler to budget. Found can still be a reasonable choice for patients who specifically want the broader coaching-and-app experience and are comfortable paying more for it.
The right comparison is not just "Which one starts cheaper?" It is "Which one gives me the right level of support at a cost I can sustain for a year?" If you are already on Found and rethinking the math, our guide to switching from Found to Trimi explains how to make the move with minimal disruption.
Frequently Asked Questions
Is Trimi cheaper than Found for semaglutide?
Yes, on published prices. For compounded semaglutide, Found charges $169 per 28-day cycle on a 12-month cash-pay plan and $289 month to month after a $179 first cycle; Trimi charges $99 per month on its annual plan (a 12-month commitment) or $175 month to month. Both prices include the medication and clinical care and stay the same at every dose, so the gap is the price itself, not hidden charges.
Why can Found feel more expensive over time?
Found bundles medication with a broader behavior-change program, app features, and a member community, and that bundle is priced above a medication-first service. Two billing details also add up over time: Found bills per 28-day cycle, so a year of month-to-month billing is 13 charges rather than 12, and the month-to-month plan's discounted first cycle rises from the second cycle ($179, then $289 for compounded semaglutide on cash pay). On Found's insurance track, visit copays sit on top of the plan price.
Does Found include coaching in the price?
Yes. Found says every plan includes its licensed medical team and a personalized care plan with medical, lifestyle, and behavioral guidance, plus 24/7 access to Aimee, its AI health companion, and a member community. There is no separate coaching or membership charge on top of the plan price, and for compounded GLP-1s the medication is included too.
Does Trimi charge more when the dose goes up?
Trimi emphasizes clearer, flatter pricing so patients can budget more predictably across the dose-escalation phase and maintenance phase. You should always verify the current plan directly, but the model is designed to avoid the dose-tier surprises that patients often worry about with broader telehealth platforms.
Which is better if I want the lowest total annual cost?
If your priority is the lowest realistic total annual cost for compounded GLP-1 access, Trimi is usually the better fit. If you specifically want a more app-centric, coaching-oriented program and are comfortable paying more for it, Found can still make sense.
Can I switch from Found to Trimi to lower my cost?
Yes. Many patients switch when they want lower monthly costs or simpler billing. The best transition plan is to start the new intake before your last Found shipment runs out so you avoid a gap in medication.
Should I compare monthly price or total yearly price?
Yearly cost is the better comparison. GLP-1 therapy usually lasts many months, so small monthly differences become meaningful over time. You should also compare what is included, such as provider visits, shipping, and whether costs change as your dose increases.
Sources & References
- Found Health. Official program information and public pricing references reviewed in April 2026.
- STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
- SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
- FDA guidance on compounding and the FDA.
- American Board of Obesity Medicine. Standards and principles relevant to obesity care delivery.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or changing any medication. Pricing information changes frequently and should be verified directly with each provider. Trimi is a competing provider and readers should evaluate both options independently.